
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75Â years
Keywords: Cost-effectiveness; Osteoporosis; Postmenopausal women; Risedronate; Strontium ranelate;